Prescription Drug News and Research

RSS

U.S. Drug Enforcement Administration to hold national drug take-back day this weekend

On April 27, the U.S. Drug Enforcement Administration will be running a national drug take-back day. It is an opportunity for everyone to safely remove unwanted, unused, or expired medication from medicine cabinets.

23 Apr 2013

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).

18 Apr 2013

Roundup: Ariz. lawmakers revive vetoed health care price transparency bill; Big tobacco starts health care payments to states

The Arizona Senate voted Monday to revive the major provisions of a medical pricing transparency bill that was vetoed by Gov. Jan Brewer just last week. Senate Bill 1115 by Republican Sen. Nancy Barto would have required health care providers to post prices for common medical procedures (Christie, 4/15).

17 Apr 2013

Updated labeling for Purdue Pharma's reformulated OxyContin tablets gets FDA approval

The U.S. Food and Drug Administration today approved updated labeling for Purdue Pharma L.P.'s reformulated OxyContin (oxycodone hydrochloride controlled-release) tablets.

17 Apr 2013

Propranolol drug can improve language abilities, social functioning of people with ASD

People with an Autism Spectrum Disorder (ASD) often have trouble communicating and interacting with others because they process language, facial expressions and social cues differently.

16 Apr 2013

First Edition: April 16, 2013

Today's headlines include coverage of the Supreme Court oral arguments regarding whether patents should be granted for human genes.

16 Apr 2013

Ameritox study shows correlation between positive marijuana tests, misuse of prescription drugs

Ameritox, one of the nation's leaders in pain medication monitoring, announced new research today showing a correlation between positive marijuana tests and higher rates of potential prescription drug non-adherence among chronic pain medication users.

15 Apr 2013

FDA accepts Otsuka Pharmaceutical's tolvaptan NDA for priority review

Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has accepted for priority review the company's new drug application for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.

15 Apr 2013

New research shows effects of long-term use of opioid therapy

Half of patients on high-dose, long-term opioid therapy had hormonal disturbances or signs of inflammation, while 100 percent reported improved pain control and mental outlook, new research shows.

15 Apr 2013

Analysis: 1 in 5 seniors with Medicare Advantage plans receive prescription for high-risk medication

More than 1 in 5 seniors with Medicare Advantage plans received a prescription for a potentially harmful "high risk medication" in 2009, according to a newly published analysis by Brown University public health researchers.

11 Apr 2013

Most Americans concerned about misuse of pain medication to treat chronic pain

A new national public opinion poll commissioned by Research!America shows only 18% of respondents believe chronic pain is a major health problem, even though a majority of Americans (63%) say they know someone who experienced pain so severe that they sought prescription medicines to treat it.

10 Apr 2013

MedeAnalytics' Accountable Care Solution selected for Mississippi's MEHRS application

MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that the State of Mississippi Medicaid has selected MedeAnalytics' Accountable Care Solution to empower the next generation of the state's Medicaid Electronic Health Records System application.

9 Apr 2013

New national study examines marijuana use and prescription drug misuse

Individuals who use marijuana recreationally are more likely to misuse other drugs, including pain-controlling, but potentially addictive narcotics, sedatives and other prescription medications, than individuals who do not use marijuana, according to a new national study issued today by Quest Diagnostics, the world's leading provider of diagnostic information services.

From Quest Diagnostics 9 Apr 2013

Viewpoints: Drugging soldiers; GOP opposition to Medicaid expansion strays from party legacy; Health law distorts market

Last year, more active-duty soldiers committed suicide than died in battle. ... Worse, according to data not reported on until now, the military evidently responded to stress that afflicts soldiers in Iraq and Afghanistan primarily by drugging soldiers on the front lines.

9 Apr 2013

FDA grants priority review for Bayer HealthCare's riociguat for treatment of CTEPH

Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Administration for the treatment of inoperable chronic thromboembolic pulmonary hypertension or with persistent or recurrent CTEPH after pulmonary endarterectomy and pulmonary arterial hypertension.

8 Apr 2013

Medicare misperceptions create tougher task for lawmakers

The New York Times reports that public misunderstandings about the specifics of entitlement benefits make trimming Medicare spending more difficult. Meanwhile, Politico reports on an idea that might bridge the partisan divide that plagues these efforts.

5 Apr 2013

Catamaran receives Specialty Pharmacy Accreditation from URAC for BriovaRx

Catamaran Corp., a leading provider of pharmacy benefit management services and technology today announced that its specialty brand, BriovaRx, has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, D.C.-based accrediting organization that establishes quality standards for the healthcare industry.

4 Apr 2013

Confirmation hearing for CMS nominee set for next week

The Senate Finance Committee will hold a session on whether to approve Marilyn Tavenner to head the agency that controls Medicare and Medicaid.

4 Apr 2013

As hyperactivity diagnoses rise, concerns grow about overmedication of children

New CDC data shows that nearly one in five boys have a medical diagnosis of attention deficit hyperactivity disorder. Other public health issues highlighted by news outlets include stroke risks in younger people, prescription-drug deaths and OSHA policies.

2 Apr 2013

pSivida announces resubmission of ILUVIEN NDA to FDA for chronic diabetic macular edema

pSivida Corp., a specialty pharmaceutical company that is a leader in the development of sustained release ophthalmic drug treatments, today announced that its licensee Alimera Sciences, Inc. reported the submission of its response to the second Complete Response Letter from the U.S. Food and Drug Administration with respect to ILUVIEN for chronic diabetic macular edema.

2 Apr 2013

Prescription Drug News and Research

U.S. Drug Enforcement Administration to hold national drug take-back day this weekend

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

Roundup: Ariz. lawmakers revive vetoed health care price transparency bill; Big tobacco starts health care payments to states

Updated labeling for Purdue Pharma's reformulated OxyContin tablets gets FDA approval

Propranolol drug can improve language abilities, social functioning of people with ASD

First Edition: April 16, 2013

Ameritox study shows correlation between positive marijuana tests, misuse of prescription drugs

FDA accepts Otsuka Pharmaceutical's tolvaptan NDA for priority review

New research shows effects of long-term use of opioid therapy

Analysis: 1 in 5 seniors with Medicare Advantage plans receive prescription for high-risk medication

Most Americans concerned about misuse of pain medication to treat chronic pain

MedeAnalytics' Accountable Care Solution selected for Mississippi's MEHRS application

New national study examines marijuana use and prescription drug misuse

Viewpoints: Drugging soldiers; GOP opposition to Medicaid expansion strays from party legacy; Health law distorts market

FDA grants priority review for Bayer HealthCare's riociguat for treatment of CTEPH

Medicare misperceptions create tougher task for lawmakers

Catamaran receives Specialty Pharmacy Accreditation from URAC for BriovaRx

Confirmation hearing for CMS nominee set for next week

As hyperactivity diagnoses rise, concerns grow about overmedication of children

pSivida announces resubmission of ILUVIEN NDA to FDA for chronic diabetic macular edema

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News